Qorvo (QRVO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Qorvo (QRVO) reported Q1 revenue of $818.78 million, a 7.7% year-over-year decline, yet it surpassed the Zacks Consensus Estimate of $774.7 million by 5.69%. The company's EPS of $0.92 significantly exceeded the $0.62 consensus estimate by 48.39%, also up from $0.87 in the prior year. Despite these beats, Qorvo shares have underperformed the S&P 500 over the past month, declining 0.7% against the index's 3.6% gain.

Analysis

Qorvo (QRVO) delivered a mixed but largely better-than-feared performance in its first quarter for fiscal year 2025. While total revenue declined 7.7% year-over-year to $818.78 million, this figure represented a significant 5.69% beat against the Zacks Consensus Estimate of $774.7 million. The bottom-line result was notably stronger, with EPS of $0.92 not only growing from $0.87 in the prior-year period but also exceeding the consensus forecast of $0.62 by a substantial 48.39%. A granular look at segment performance reveals that the overall revenue contraction was driven by an 11.1% YoY decline in the company's largest segment, Advanced Cellular Group (ACG), and a 4.1% dip in the Connectivity and Sensors Group (CSG). However, the High Performance Analog (HPA) segment provided a bright spot with 6.1% YoY growth. Crucially, all three segments surpassed their respective analyst revenue estimates, indicating broad outperformance relative to expectations. Despite these positive surprises on earnings and revenue, the stock's recent performance has lagged, returning -0.7% over the past month compared to a 3.6% gain for the S&P 500 composite, suggesting investor sentiment remains tempered by the headline revenue decline.

Key Decisions for Investors

• Investors should weigh the strong operational performance, evidenced by the significant EPS beat, against the persistent year-over-year revenue decline, particularly in the core Advanced Cellular Group (ACG).
• Given the stock's recent underperformance despite the earnings surprise, it may be prudent to monitor for signs of revenue stabilization in the ACG and CSG segments before increasing exposure.
• The outperformance of the High Performance Analog (HPA) segment is a key positive, and its continued growth trajectory should be assessed as a potential offset to weakness in other areas.